Introduction ablation in tissues with low mitotic indices. [2] [3] [4] In these Gene directed enzyme prodrug therapy (GDEPT) is being cases the mode of action of the activated prodrug is developed as a treatment for cancer and other pathologiunclear although in nonproliferating thyrocytes it apparcal conditions. It involves expression of a gene encoding ently occurs by p53-independent apoptosis. 5 A second an enzyme which converts an inactive prodrug to a cytoproblem with HSV1-tk is that this gene is expressed toxin. For gene therapy, selectivity of killing comes from ectopically in the testis from an internal cryptic promoter both the route of gene delivery and from the specificity causing male sterility and results in considerable diffiof the regulatory elements used to direct expression. The culties in the establishment of breeding lines. 6 It has been main requirements are that enzyme expression does not shown recently that a truncated HSV1-tk does not cause affect cells in the absence of the prodrug, which should this problem although cells carrying this modified gene not be toxic in its own right or converted to a toxin in are considerably less sensitive to killing by ganciclovir. 7 the absence of the enzyme. The activated prodrug should In this report we describe a new system for achieving kill the target cells efficiently and, if selective ablation is the inducible ablation of specific cell types in transgenic required, should not affect nearby nonexpressing cells.
mice that overcomes many of the problems associated Similarly, gene-prodrug combinations have been used with HSV1-tk. It is based on the E. coli enzyme nitroin transgenic mice to achieve the selective ablation of cells reductase (NTR) which activates certain nitro comto address the basis question of cellular physiology and pounds, such as the antitumour drug CB1954 (5-aziridindevelopment. As for certain applications of GDEPT, this 1-yl-2-4-dinitrobenzamide), to potent cytotoxic agents. 8 has been exemplified using the herpes virus type 1 thymWe have generated transgenic mice which express this idine kinase (HSV1-tk). The phosphorylated products of gene specifically in the luminal epithelial cells of the prodrugs such as FIAU or ganciclovir are nucleotide anamammary gland and shown that CB1954 administration logues and kill by causing chain termination when they rapidly and selectively kills these cells. Owing to the ease are incorporated into cellular DNA during replication.
of control of NTR mediated cell ablation, we anticipate Thus FIAU-treatment of transgenic mice carrying HSV1-that this system will supercede HSV1-tk. There are widetk targeted to the pituitary with the growth hormone prospread potential applications for this approach in the dismoter resulted in the ablation of the somatotroph and section of complex cellular interactions during developlactotroph cells. 1 By contrast, lactotrophs from transgenic ment and in the adult organism. The present transgenic mice expressing HSV1-tk under the control of the prolactin promoter were unaffected by FIAU treatment. This model also has important applications for the study in was thought to be due to the fact that prolactin vivo of novel prodrugs that can be selected for variable expression is activated postmitotically. Recently the view degrees of bystander effects. Such studies will have partithat HSV1-tk-mediated killing by FIAU or ganciclovir cular significance to those groups advocating the use of requires cell proliferation has been challenged by a NTR as an appropriate enzyme for GDEPT 9 by providing models of a wide range of human disease for mechanistic and therapeutic experimentation. The model described in this work has potential for the examination of mammary Results CB1954 kills NTR-expressing mammary cells in culture HB4a, an SV40 conditionally immortalised human luminal epithelial cell line was transfected with pNTRR8/3 or the pREP8 vector control ( Figure 1 ) and stable transfectants selected (see Materials and methods). Pooled populations of transfected cells were expanded and examined for NTR expression. Immunoblotting of whole cell lysates using a rabbit polyclonal antibody showed that the cells transfected with pNTRR8/3 expressed readily detectable amounts of NTR protein with the same electrophoretic mobility as recombinant E. coli NTR (Mr, approximately 24 kDa). This protein was biologically active as shown by its ability to reduce CB1954 to produce both the 2-and fected with pNTRR8/3 and with empty vector were exposed to varying concentrations of CB1954 and the produced about six cross-links and 25 breaks per 10 9 dalgrowth curve of the cells examined over 6 days. Figure  tons , while 50 m CB1954 produced 12 cross-links and 2 shows a dramatic difference in survival between the 28 breaks. These effects were not seen in untreated cells empty vector and NTR-expressing cells at concentrations (data not shown). of 10-40 m CB1954 noted as early as 48 h after CB1954 treatment. These results demonstrate that CB1954 can
The ␤-lactoglobulin promoter targets NTR expression to efficiently kill NTR-expressing mammary epithelial cells.
the mammary gland in transgenic mice DNA cross-linking was detected by alkaline sucrose Promoter sequences from the ovine ␤-lactoglobulin (BLG) gradient sedimentation. 10 Increasing amounts of CB1954 gene were used to target NTR expression specifically to caused a progressive increase of cross-linking in NTRthe mammary gland. 11 In these experiments the BLGexpressing HB4a cells, as indicated by the greater pro-NTR transgene ( Figure 1 ) was co-injected with the portion of higher molecular weight DNA sedimenting unmodified BLG gene; we have shown previously that further into the gradient. DNA strand breakage (either co-integration with the BLG gene can enhance the frank breaks or alkali labile sites ) was also observed.
expression of constructs targeted to the mammary Under the conditions employed, 10 m of CB1954 gland. 12 Three founder mice carrying both NTR and BLG transgenes were generated. Two of these, RED 20 (approximately 15 copies BLG/four copies of NTR) and RED40 (approximately 15 copies BLG/approximately 12 copies NTR), cosegregated both transgenes in the next generation and breeding lines were established. Both lines exhibited normal fertility.
Transgene expression was investigated in lactating females from the RED20 and the RED40 lines. Analysis of tissue samples by SDS-PAGE followed by Western blotting with a polyclonal antibody to NTR revealed a single band of approximately 24 kDa (the predicted Mr for NTR) in mammary gland samples from RED40 mice. Mammary samples from RED20 and control mice were negative as were the liver samples from both lines and the controls (data not shown). Northern blotting experiments revealed an approximately 1000 nt NTR transcript in total mammary gland RNA from RED40 ( Figure 3 ). No NTR mRNA was detected in the liver, spleen or kidney from RED40 mice although a trace of signal was evident in the salivary gland (data not shown). NTR transcripts were not detected in RED20 mice. Both lines exhibited high levels of BLG transgene mRNA in the mammary gland. reducing activity were present in control samples taken during gestation and pregnancy. Transgene expression was restricted to the luminal cells, however, for NTR a mosaic pattern of expression was observed. In line RED40 large contiguous patches of nonexpressing cells were evident amidst the expressing cells (Figure 5a ). In the expressing cells the staining was diffuse and cytoplasmic. There was substantial variation between individual mice killed during gestation in the percentage of luminal cells expressing the NTR transgene ranging from 10-80%, although in lactating animals more than 70% of the cells were expressing. Within the patches of expressing cells the NTR staining was generally homogeneous although in some lobules individual cells did appear to be very highly expressing. In the majority of mice from line RED 20 we were unable to detect NTR expression, although positive foci of expression were observed in two out of 10 individuals.
In both lines the expression of BLG was uniformly positive in lobules with lipid accumulation or secretory activity in all the animals investigated (data not shown). The morphology and general appearance of the mam- administered normally at a dosage of 50 mg/kg bw either singly or at three successive 24-h intervals and the animals were killed at 48 h, 72 h or 7 days after the first administration. Two control groups were used in this study, mock-injected transgenics and CB1954-injected nontransgenic F1 control mice. No gross effects of the administration of CB1954 on the whole animal were observed during late gestation either on the experimental or control animals of either line. By contrast, the lactation failed in a number of the RED40 mice given the prodrug at this stage (Table 2) , whereas no such effects were observed in line 20 or in the control mice.
CB1954 administration had no discernible effects on the overall structure and size of the mammary glands taken at gestation. Inspection of whole mounts of mammary gland taken from lactating RED40 mice showed that much of the alveolar tissue was destroyed in treated whereas low levels of activity were detected in the samples from line RED20 and high levels were present glands giving rise to a 'moth-eaten' appearance, but the basic ductal structure was still evident (Figure 5c and d). in the RED40 samples. Thus, even though NTR mRNA and protein were not detected in line RED20, low level Histological examination of CB1954 treated RED40 mice showed a heterogeneous disruption to the normal transgene expression was detected in this line as evidenced by the measurement of biological activity in the morphology of the gland compared to controls with distorted and shrunken lobules interspersed with apparmammary gland. NTR activity was confirmed by CB1954 reduction to the 2-hydroxylamine ( Figure 4b) ; an equal ently normal pregnant and lactating lobules (Figure 5e and f). The disruption of the glands was caused by death proportion of the 2-and 4-hydroxylamines was observed in the active samples (data not shown).
of the luminal cells and the concomitant collapse of the lobules. Replacement by spindle cells, polymorphs and BLG and NTR antisera were used to localise the transgene products on sections of mammary gland tissue interlobular stroma could be seen at higher magnification 
of lactation. Test animals (c, e and g) received 50 mg/kg bw of CB1954 on days 4-6; transgenic controls (d, f and g) were mock injected with arachis oil. Sections a and b were stained with antiserum to NTR; expression of NTR is patchy (a) with no expression in the nontransgenic control (b). (c) A whole mount of the day 7 lactating gland shows a 'moth eaten' appearance after CB1954 treatment, compared with the normal gland in (d). Panels e-h were stained with haematoxylin and eosin. (e) Low power view of the gland after CB1954 treatment compared with (f), the mockinjected control. (g) Shows a high power view of the gland in (e) with apoptotic cell death (small arrow) and necrosis (large arrows) evident. The mockinjected gland in (h) shows normal secretion and no apoptosis.
The percentage of cells exhibiting apoptotic bodies was estimated from total counts of about 1500 cell nuclei from NR-stained sections.
( Figure 5g and h). In some animals there was clear were strongly positive for NTR and BLG expression (Figure 6a and c). In the lobules in which the dying phase evidence of focal reorganisation of the gland with redistribution of the glandular tissue and adipose tissue.
was complete the residual cells were not luminal cells and did not express NTR or BLG (Figure 6b and d). The effects of CB1954 administration were dosagedependent. Lactating animals given single or triple doses of CB1954 at 50 mg/kg bw exhibited considerably more NTR-mediated ablation by CB1954 is via apoptosis On routinely stained sections it was apparent that both cell death in the mammary gland than animals given a 10 mg/kg bw dosage and at a dosage of 2 mg/kg bw individual cell apoptosis and confluent necrosis was taking place after CB1954 administration (Figure 5g ; Figure little or no effect of the prodrug was observed (Table 2) .
Northern blotting analysis of mammary tissue from 6a and c).The high levels of apoptosis induced in the mammary gland of RED40 mice by administration of the lactating RED40 mice showed that administration of CB1954 at the highest dosage (50 mg/kg bw) virtually prodrug was confirmed using the apoTag staining kit (Cat no. S7100; Oncor, Gaithersburg, MD, USA). A high abolished NTR transcripts in the mammary gland but these were still evident in animals treated with lesser frequency of positively staining nuclei was observed in patches of mammary gland undergoing ablation, amounts of the prodrug (Figure 3) . By contrast, the signal from the BLG mRNA transcripts was evident in total whereas in nonexpressing patches within the mammary gland of RED40 mice and control mammary glands only mammary gland RNA from all the treated animals suggesting that the BLG expression was not confined to the occasional apoptoses were seen (Figure 6e) . To assess the dose-response effect of the prodrug, patches of NTR-expressing epithelia.
These results were confirmed by immunocytochemical apoptotic bodies and cells undergoing necrosis were counted in treated animals and controls. To quantify the localisation of NTR and BLG. In CB1954 treated RED40 animals three staining patterns were evident. Lobules extensive cell death of the luminal cells we assessed the percentage of cell kills in the NTR expressing cells of lobthat did not express NTR were unaffected by CB1954. In lobules with marked active apoptosis (as judged by the ules with the most extensive cell death (see Materials and methods). These areas were positively selected rather presence of apoptotic bodies and necrosis) the dying cells 
e). The normal distribution of myoepithelial cells stained for actin is seen in (f) compared with the accentuation of these cells seen in glands that are undergoing ablation (g and h). The sparing of the actin-positive cells is clearly seen after inflammation has resolved (h).
than by a random cell count owing to the heterogeneity or NADPH this enzyme catalyses the reduction of CB1954 to its 4-hydroxylamino derivative which is cytoof NTR expression in the gland. There was a very clear dose-response relationship with 50 mg/kg bw giving toxic to cells, even those that are resistant to CB1954. 16 It is thought that a second esterification step, common to all most extensive killing and the highest percentage of apoptotic bodies (Table 2) . cells, is required for activation and leads to derivative(s) capable of reacting with DNA to produce interstrand cross-links. 16 The bioactivation of CB1954 results in a vast CB1954 selectively destroys the luminal cells in the increase in its cytotoxicity and the resulting dose modifimammary gland of BLG-NTR transgenic mice cation can be up to 100 000-fold for certain cells. 16 The The BLG promoter targets expression specifically to the human and mouse forms of DT diaphorase, however, luminal cells of the mammary gland 14 although somereduce CB1954 very poorly 17 and therefore, cells from times very low levels of transgene expression are these species are not sensitive to this prodrug. observed at ectopic sites such as the salivary gland. 15 No Nitroreductase (NTR) proficient strains of bacteria are significant NTR expression was observed in other tissues sensitive to CB1954 18 and a NTR enzyme has been purand no histopathological effects of CB1954 were observed ified from E. coli B. 19 CB1954 is reduced about 90-fold either in the liver or the salivary gland of RED40 mice or more rapidly by the E. coli enzyme than by rat DT F1 controls (data not shown).
diaphorase. It can reduce menadione and uses NADH or In the mammary gland the luminal cells are closely NADPH as cofactor. It is, however, a much smaller proassociated with the myoepithelial cells and any effects of tein than DT diaphorase (24 kDa versus 33.5 kDa) and CB1954 on this cell population would be indicative of there is no obvious sequence homology between the two bystander effects. Smooth muscle actin is an excellent enzymes. Furthermore, NTR reduces CB1954 to produce marker of the myocytes in the vessel walls and of myoepa mixture of both 2-and 4-hydroxylamines while DT proithelial cells. During pregnancy and lactation the myoepiduces only the 4-hydroxylamine.
20
thelial cells become attenuated and stretch around the Recently, the gene encoding E. coli B NTR (nfnB) was expanding lobules in close contact with the luminal cells.
cloned and its nucleotide sequence determined. 21 In our In this situation they are only seen as thin interrupted initial experiments the modified NTR gene was expressed strands of actin-containing cytoplasm and the occasional in an immortalised mammary epithelial cell line HB4a. peripherally placed spindle shaped nucleus (Figure 6f) .
The results showed that expression of this gene in the When the alveoli collapsed as NTR-expressing luminal cells increased their sensitivity to killing by CB1954 after cells were ablated, the actin-positive cells were accentua short exposure period. The formation of DNA ated (Figure 6g ). The myoepithelial cells were apparently interstrand links provides further evidence that bioactivunaffected by administration of the prodrug and there ated forms of CB1954 produced by E. coli NTR are similar was no indication of cell killing in this cell type in alveoli to those generated by DT diaphorase and exert their cytoin which the luminal cells were undergoing extensive toxic effect by cross-linking DNA. NTR-mediated sensinecrosis. In areas of the gland where the luminal death tivity to CB1954 for other mammalian cell types (NIH3T3, phase was complete the lobules were completely disorhuman melanoma, ovarian carcinoma and mesothelioma) ganised and actin staining showed that they were comhas been reported recently. 9 posed almost entirely of myoepithelial cells (Figure 6h ). The nuclei of these cells were intact and there was no NTR expression in the mammary gland indication of cell death in this cell type. The killing by
The success of the work in cultured mammary epithelial CB1954 was restricted to the NTR-expressing luminal cells encouraged us to test the efficacy of NTR-mediated cells and there was no evidence of a bystander effect killing by CB1954 in vivo using transgenic mice. To target upon the closely associated myoepithelial cells even 7 NTR expression to the mammary gland we used regulatdays after the initial administration of the prodrug. ory elements derived from the ovine BLG gene. We have There was no evidence of cellular toxicity to CB1954 in previously shown that the BLG gene is expressed specifiany other cell types in the breast. Endothelial cells, adipocally and efficiently in the luminal cells of the mammary cytes and fibroblasts showed no evidence of apoptosis or gland of transgenic mice 11, 14 and that regulatory elements single cell necrosis that might be expected if there was a from this gene can be used to target the expression of a significant bystander effect. In areas of extensive luminal variety of heterologous gene sequences to this tissue. 15, 22 necrosis there was an associated infiltration by polyProkaryotic sequences such as E. coli NTR can be difficult morphonuclear leukocytes. Another feature seen in the to express in transgenic mice and therefore, we cointeglands that were past the luminal cell death stage was grated the BLG-NTR transgene with the unmodified BLG an extensive epithelial hyperplasia within the terminal gene. This is the strategy that we have previously ducts.
employed to enhance the efficiency of expression of otherwise poorly expressed gene constructs.
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Discussion
The two transgenic (RED) lines carrying BLG-NTR and BLG expressed both transgenes although only RED40 mice expressed appreciable levels of the bacterial gene.
CB1954 and nitroreductase CB1954 (5-aziridin-1-yl-2-4-dinitrobenzamide) attracted
The difference between the two lines presumably reflects position effects at the site of integration, a common attention more than three decades ago because of its dramatic and selective activity against rat Walker 256 phenomenon with transgenic animals. A complication in the analysis was revealed by the immunocytochemical tumours. The basis of this antitumour activity was subsequently shown to be due to the presence of high levels analysis of NTR expression in the mammary gland of RED40 mice which revealed a mosaic pattern of NTR of a nitroreductase enzyme in these cells which was found to be DT diaphorase. 8 In the presence of NADH expression; large patches of cells expressed the transgene whereas other patches were completely negative for the effects of CB1954 in these cells. In some areas of the gland the death phase was complete after 48 h with the comtransgene product. Variegated patterns of transgene expression have been noted in transgenic mice carrying plete collapse of alveolar structures and the disappearance of the luminal cells. NTR mRNA transcripts appear fatty acid binding protein fusion genes, 23 tyrosinase fusion genes, 24 CD2 25 and ␣ 26 and ␤ 27 globin-derived to be sensitive to CB1954 treatment and were reduced to a very low level after 3 days, whereas NTR-staining cells transgenes. We have also reported variegated expression of BLG transgenes in the mammary gland of certain lines were still evident in tissue sections; this presumably reflects the greater half-life of the protein during the of transgenic mice. In these mice, the mosaic pattern of BLG was very similar to that observed for NTR in this death of the cells. present study and was correlated with variable levels of transgene expression within the line. This pattern of Absence of bystander effects From all the available evidence the NTR-mediated killing expression appears to be a consequence of the chromosomal location and/or nature of the integration site. 28 of luminal cells by CB1954 was quite specific to this cell type and the closely associated myoepithelial cells appeared unaffected. At the end of the death phase, NTR-mediated cell ablation with CB1954 Although NTR was not expressed uniformly within the when the luminal cells had been removed, the collapsed alveoli comprised little more than intact myoepithelial luminal cells of RED40 this did not prove to be a problem when it came to assessing the effects of CB1954 adminiscells and there was no evidence that these cells were undergoing apoptosis (Figure 6g and h) even 7 days after tration. Indeed, in certain respects it proved quite advantageous because expressing and nonexpressing cells the initial prodrug administration. This contrasts with previous reports of significant bystander effects observed could be treated and viewed simultaneously within a single section. At a dosage of 50 mg/kg bw CB1954 had in culture when CB1954-treated Walker tumour cells were cultured with otherwise insensitive V79 29 , or NTRa devastating effect on expressing cells during gestation and lactation and large areas of the gland were expressing NIH3T3 cells were cocultured with nonexpressing cells. 9 destroyed. The effects of prodrug administration were apparent as early as 48 h after the initial administration. The use of NTR for selective ablation of cells in transgenic mice may have significant advantages over the Some variability of the effects, particularly during gestation, were observed and, for example, mice given the HSV1-tk. In the luminal population of the mammary gland it is clearly very effective and widespread cell same single 50 mg/kg bw dose of CB1954 and killed 48 h and 72 h after administration showed different degrees death was apparent only 48 h after the first inoculation. Efficient cell killing by CB1954 does not require cell proof ablation (Table 1) . This may reflect differences in the degree of mosaic expression of NTR between the mice liferation. 9 In the present study this was evidenced by the fact that lactating cells, which have a very low mitotic but, probably, it is related to the heterogeneous nature of the still developing alveolar tissue at this stage which index 13 are sensitive. This is not surprising since we know that activated CB1954 cross-links DNA and we presume makes assessment of the proportion of cell death difficult. During lactation alveolar development is complete and this is the trigger for apoptosis and predict that any NTRexpressing cell will be sensitive irrespective of its metathe secretory tissue fills the mammary fat pad. CB1954 administration at this stage gave a more consistent effect bolic or proliferative state. Secondly, no side-effects associated with carrying or expressing NTR were observed and we estimated roughly that 60-80% of the alveolar tissue was disrupted at the maximal dose. Nondisrupted in the lines of transgenic mice generated and both sexes were fully fertile. Thirdly, the pharmacokinetics and toxalveolar structures did not express NTR. Thus NTRmediated ablation by CB1954 provides a highly effective icity in mice and other animals of CB1954 are well established. 30, 31 This compound readily crosses the bloodmeans of destroying mammary luminal cells in vivo; most if not all NTR-expressing cells are dead or dying as early brain barrier and therefore we anticipate that it will be feasible to target specific cell types within the CNS, which as 48 h after the initial administration of the prodrug.
In these studies no gross toxicological effects of CB1954 to our knowledge has yet to be accomplished using HSV1-tk. CB1954 is readily administered by i.p. injection administration were observed other than in the mammary gland of NTR-expressing mice. Two other tissues, whereas most ablation studies using HSV1-tk have used mini-pumps. 1, 3, 4 liver and salivary gland, were investigated histologically after prodrug administration and exhibited no abnorDespite the fact that bystander effects have been observed with CB1954 in cell culture, 9, 29 it is interesting malities. Interestingly, in clinical trials of CB1954 on human cancer patients carried out some years ago the to note that our results in the mammary gland indicate that cell killing is quite specific and that in this tissue main side-effect was severe diarrhoea (Dr E Wiltshaw, personal communication) and possibly this was caused these effects are at a minimum. Whilst the generality of this lack of bystander effects in vivo awaits further experby effects of CB1954 on NTR-expressing bacteria in the gut.
imentation in other tissues, these results encourage us to believe that the ablation of specific cells in tissues such the pituitary, gut, pancreas, CNS and immune system, The mechanism of cell death is apoptosis NTR-expressing luminal cells die by apoptosis initiated which like the mammary gland comprise more than one cell type in close association can be accomplished with by CB1954 treatment, presumably as a consequence of DNA cross-linking. The frequency of apoptosis observed this approach. We plan to use this approach in the mammary gland to study not only the developmental relationin the luminal cells of the mammary gland was extremely high. Such a high frequency is rarely observed in vivo ship between the different cell but also the origin of the patches of transgene expressing versus nonexpressing because of the rapid removal of apoptotic cells by phagocytosis and serves to emphasise the potent cytotoxic cells.
The selective activation of CB1954 and related pro-(NADH menadione oxido-reductase) activity and reduction of CB1954. NMOR activity was assayed by a drugs may offer the potential of novel anticancer strategies by GDEPT. In this regard transgenic mice carrying spectrophotometric method as previously described 19 employing menadione as substrate at a concentration of NTR transgenes should provide a powerful model to assess the efficacy of tumour cell killing in vivo. This 500 m and cytochrome C as electron acceptor. Activity was defined as the cytochrome C reduction inhibited by could be accomplished by directing expression to the precancerous cell and then inducing tumours with the 100 m dicoumarol and expressed as nmoles of cyto- Figure 1 ). This same fragment was subchemistry dewaxed sections were pretreated with 0.1% sequently blunt-ended using Klenow polymerase (w/v) trypsin in PBS for 10 min at 37°C for antigen (Boehringer Mannheim, Lewes, UK) and cloned into the retrieval. Endogenous peroxidase was blocked with 1% unique EcoRV site of the BLG-derived plasmid (v/v) hydrogen peroxide. After blocking block nonspeexpression vector pBJ41 to produce the BLG-NTR concific antibody binding in 5% (v/v) normal swine serum struct ( Figure 1 ).
(Dako, Glostrup, Denmark) the sections were incubated HB4a, an SV40 conditionally immortalised human for 1.5 h at 37°C with the appropriate primary antibody breast luminal cell line, was transfected with pREP8 and diluted in PBS (1) anti-NTR (1:200); (2) anti-BLG (1:2000); pNTRR8/3 using calcium phosphate precipitation, and (3) monoclonal anti-mouse ␣-smooth muscle actin ascites stable transfectants selected with 1 mm histidinol. For (1:10 000; A2547; Sigma, Poole, UK). After washing in PBS each plasmid 50-60 drug-resistant colonies were obtained sections were incubated with the secondary antibody for which were then pooled and maintained continuously 1 h at room temperature. For (1) and (2), 1:200 swine antiunder selection. The 9.9 kb BLG-NTR insert was isolated rabbit Ig biotinylated antibody (Dako; E0353) or for (3) from the plasmid by restriction enzyme digestion and gel 1:300 rabbit anti-mouse Ig biotinylated antibody (Dako; electrophoresis. The 10.8 kb BLG gene fragment ( Figure  E0354 ). Sections were washed in PBS and incubated with 1) from the BLG clone pSS1tgXS 33 was similarly prestreptavidin-peroxidase conjugate (Zymed, San Francipared. The two fragments were mixed in 3:1 (BLG:BLGsco, CA, USA) at 1:2000 for 30 min at room temperature NTR) and injected into pronuclear eggs derived from in the dark. The colour was developed by incubation matings of F1 C57Bl6/CBA mice as previously with a DAB/H 2 O 2 solution for 10 min. Sections were described. 12 Tail DNA was prepared from putative transcounterstained with haematoxylin, dehydrated and genic mice and analysed by Southern blotting. mounted in DPX. In situ apoptosis was detected using the apoTag kit. The test works by linking digoxigeninnucleotides to DNA 3′OH ends which are generated durExpression analysis RNA was prepared using RNAzol (Biogenesis, Poole, ing apoptosis, using terminal deoxynucleotidyl transferase. The digoxigenin-labeled ends are detected by peroxi-UK) and fractionated on 1.5% formaldehyde/agarose gels. Blots were probed with radiolabelled NTR, BLG and dase conjugated antidigoxigenin antibody and DAB. For the quantitative analysis, cell sections stained with the glyceraldehyde 3′phosphate dehydrogenase (GAPDH) probes as previously described. 34 Tissue samples antibody to NTR and counterstained with haematoxylin were used in preference to the apoTag-stained material (approximately 0.1 g) were thawed into 1 ml of lysis buffer (1% NP40, 1% aprotinin in PBS) at 4 o C and disbecause the methyl green counterstain used with this stain gave poorly defined cellular structures. By contrast, rupted by homogenisation, centrifuged and the supernatant used to determine NTR activity by both its NMOR the haematoxylin-counterstained sections gave well
